Table 5 QoL in the two studied groups after injection and comparison between before (Table 4) and after injection
Group 1 (MTP group) ( N = 45) | Group 2 (TMC group) ( N = 45) | Test of significance | p -value | |||
|---|---|---|---|---|---|---|
Mobility | ||||||
No problems | 15 | 33.3% | 13 | 28.9% | MC = 0.572 | 0.966 |
Slight problems | 15 | 33.3% | 16 | 35.6% | ||
Moderate problems | 6 | 13.3% | 8 | 17.8% | ||
Severe problems | 5 | 11.1% | 4 | 8.9% | ||
Extreme problems | 4 | 8.9% | 4 | 8.9% | ||
P1 | < 0.001* | < 0.001* | ||||
Self-care | ||||||
No problems | 19 | 42.2% | 20 | 44.4% | MC = 1.453 | 0.835 |
Slight problems | 14 | 31.1% | 16 | 35.6% | ||
Moderate problems | 7 | 15.6% | 4 | 8.9% | ||
Severe problems | 3 | 6.7% | 4 | 8.9% | ||
Extreme problems | 2 | 4.4% | 1 | 2.2% | ||
P1 | < 0.001* | < 0.001* | ||||
Usual activities | ||||||
No problems | 18 | 40% | 18 | 40% | MC = 2.094 | 0.719 |
Slight problems | 18 | 40% | 19 | 42.2% | ||
Moderate problems | 4 | 8.9% | 6 | 13.3% | ||
Severe problems | 4 | 8.9% | 2 | 4.4% | ||
Extreme problems | 1 | 2.2% | 0 | 0% | ||
P1 | < 0.001* | < 0.001* | ||||
Pain/discomfort | ||||||
No problems | 19 | 42.2% | 20 | 44.4% | MC = 0.908 | 0.923 |
Slight problems | 15 | 33.3% | 17 | 37.8% | ||
Moderate problems | 6 | 13.3% | 5 | 11.1% | ||
Severe problems | 4 | 8.9% | 2 | 4.4% | ||
Extreme problems | 1 | 2.2% | 1 | 2.2% | ||
P1 | < 0.001* | < 0.001* | ||||
Anxiety depression | ||||||
No problems | 18 | 40% | 17 | 37.8% | MC = 1.204 | 0.877 |
Slight problem | 15 | 33.3% | 16 | 35.6% | ||
Moderate problems | 8 | 17.8% | 8 | 17.8% | ||
Severe problems | 3 | 6.7% | 4 | 8.9% | ||
Extreme problems | 1 | 2.2% | 0 | 0% | ||
P1 | < 0.001* | < 0.001* | ||||